• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Case of persistent false elevation of prostate-specific antigen after radical prostatectomy].

作者信息

Shida Yohei, Imasato Yushi, Tsurusaki Toshifumi, Kusaba Yasuyuki

机构信息

Department of Urology, Kamigoto Hospital.

出版信息

Hinyokika Kiyo. 2010 Apr;56(4):233-5.

PMID:20448449
Abstract

We report a rare case of persistent false elevation of prostate-specific antigen (PSA) after radical prostatectomy (RP). Preoperative total PSA was 25.4 ng/ml and final pathology was Gleason score 3+5=8, pT3aN0M0. His first postoperative total PSA was 3.85 ng/ml. He received adjuvant hormone therapy for 10 months. Since PSA gradually elevated despite adjuvant hormone therapy, he underwent imaging for metastasis, confirming no evidence of prostate cancer recurrence. Moreover, total PSA was unmeasurable level in three other PSA assays.

摘要

相似文献

1
[Case of persistent false elevation of prostate-specific antigen after radical prostatectomy].
Hinyokika Kiyo. 2010 Apr;56(4):233-5.
2
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.对于具有不良病理特征的前列腺癌患者，根治性前列腺切除术后辅助放疗可改善生化结局。
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24. doi: 10.1016/j.ijrobp.2004.06.018.
3
Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.前列腺癌根治术后假性前列腺特异性抗原（PSA）复发：人抗鼠嗜异性抗体的干扰
Int J Urol. 2007 Mar;14(3):251-3. doi: 10.1111/j.1442-2042.2006.01648.x.
4
Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.根治性前列腺切除术后切缘阳性患者中预测辅助放疗反应的因素的识别。
J Urol. 2003 Nov;170(5):1860-3. doi: 10.1097/01.ju.0000092503.45951.c2.
5
Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.使用基于前列腺特异性抗原密度和活检Gleason评分的新型风险分组系统改善根治性前列腺切除术后生化复发的风险分层。
J Urol. 2002 Jul;168(1):110-5.
6
Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.术前血清前列腺特异性抗原水平在2至22纳克/毫升之间与根治性前列腺切除术后的癌症形态相关性较差：前列腺特异性抗原治愈率在2至9纳克/毫升之间似乎保持不变。
J Urol. 2002 Jan;167(1):103-11.
7
Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.前列腺癌根治术后可检测到前列腺特异性抗原的适形放疗：复发的疗效及预测因素
Can J Urol. 2009 Oct;16(5):4813-9.
8
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.临床局限性前列腺癌单纯根治性前列腺切除术后临床及病理因素与前列腺特异性抗原水平升高的相关性
Urology. 1996 Aug;48(2):249-60. doi: 10.1016/S0090-4295(96)00167-7.
9
[PSA and follow-up after treatment of prostate cancer].[前列腺癌治疗后的前列腺特异性抗原（PSA）及随访]
Prog Urol. 2008 Mar;18(3):137-44. doi: 10.1016/j.purol.2007.12.010. Epub 2008 Apr 18.
10
Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.阳性活检核心的百分比、术前前列腺特异性抗原（PSA）水平、pT和Gleason评分作为根治性前列腺切除术后PSA复发的预测指标：日本一项多机构结局研究
BJU Int. 2006 Sep;98(3):549-53. doi: 10.1111/j.1464-410X.2006.06379.x.